Hangzhou, China

Xiangyun Tu

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kind Pharmaceutical. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangyun Tu. Retrieved from https://idiyas.com/inventor/xiangyun-tu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Xiangyun Tu in Pharmaceutical Chemistry

Introduction

Xiangyun Tu is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on indolizine derivatives. With a total of 4 patents to his name, Tu's innovations are paving the way for advancements in medical applications.

Latest Patents

Among his latest patents, Tu has developed indolizine derivatives and their application in medicine. This invention focuses on novel substituted indolizine derivatives, which can include isotopically labeled compounds, optical isomers, geometric isomers, tautomers, or mixtures of various isomers. Additionally, these compounds can be presented as pharmaceutically acceptable salts or prodrugs. The invention emphasizes the potential use of these compounds in medical applications, showcasing Tu's commitment to advancing healthcare solutions.

Career Highlights

Xiangyun Tu is currently associated with Kind Pharmaceutical, where he continues to innovate and contribute to the field. His work has garnered attention for its potential impact on medicine, particularly in developing new therapeutic agents.

Collaborations

Tu collaborates with talented individuals in his field, including Dong Liu and Dongdong Chen. These partnerships enhance the research and development process, leading to more robust innovations.

Conclusion

Xiangyun Tu's contributions to pharmaceutical chemistry through his patents on indolizine derivatives highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…